| Introductory Remarks Shawn Erickson |
Ligand Twisting and Counterion Switching in Rhodopsin Activation
Thomas P. Sakmar, The Rockerfeller University, New York, NY |
Using Designed Peptide Panels for De-risking GPCR Projects
Waleed Danho, Hoffmann-La Roche, Nutley, NJ |
GPCR Ligands from Enzyme Targeted Libraries
Michael Ohlmeyer, Pharmacopeia, Cranbury, NJ |
Coffee Break |
Discovery and Development of the First Centrally Active mGluR5 Positive Allosteric Modulators
Craig Lindsley, Merck & Co, Inc., West Point, PA |
A LMW CCR5 Antagonist in Combination with CsA Prolongs Graft Survival in Life Supporting Kidney TX Model in Cynomolgus Monkeys
Gerhard Thoma, Novartis Pharma AG, Basel, Switzerland |